Bivalirudin, Human

Size

£460.00

SKU:: B2102-50
Purity:: ≥ 95% by RP-HPLC, FPLC, or reducing/non-reducing SDS-PAGE Silver Stain. Chromatographically purified. Endotoxin: < 0.1ng/ug (IEU/ug) of Bivalirudin.
Storage Conditions:: -20°C
Supplier:: United States Biological
Format:: Supplied as a lyophilized powder in manntiol, sodium hydroxide, pH 5.5. Reconstitute with sterile ddH2O, 0.1% BSA or HSA to a concentration of >100ug/ml, which can then be further diluted to other aqueous solutions.
Extra Details:: Bivalirudin is a specific and reversible direct thrombin inhibitor. Bivalirudin is indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty. Human Bivalirudin is a synthetic 20 amino acid peptide. MW: 2180 Daltons Sequence (linear): Phe-Pro-Arg-Pro-Gly-Gly-Gly-Gly- Asp-Gly-Asp-Phe-Glu-Glu-Ile- Pro-Glu-Glu-Tyr-Leu Dimers and Aggregates: ≤ 1% as determined by silver-stained SDS-PAGE gel analysis. Protein Content: Protein quantitation was carried out by two independent methods: 1. UV spectroscopy at 280nm. 2. Analysis by RP-HPLC. Storage and Stability: Lyophilized powder may be stored at 4°C for short-term only. Stable for 12 months at -20°C. Reconstitute to nominal volume (see reconstitution instructions for peptides) and store at -20°C. For maximum recovery of product, centrifuge the original vial prior to removing the cap. Further dilutions can be made in assay buffer.